BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 30312990)

  • 1. Impact of residual coronary atherosclerosis on transfemoral transcatheter aortic valve replacement.
    Li J; Patel SM; Nadeem F; Thakker P; Al-Kindi S; Thomas R; Makani A; Hornick JM; Patel T; Lipinski J; Ichibori Y; Davis A; Markowitz AH; Bezerra HG; Simon DI; Costa MA; Kalra A; Attizzani GF
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):545-552. PubMed ID: 30312990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of coronary artery disease and percutaneous coronary intervention in women undergoing transcatheter aortic valve replacement: From the WIN-TAVI registry.
    Guedeney P; Tchétché D; Petronio AS; Mehilli J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Iadanza A; Sardella G; Van Mieghem NM; Sorrentino S; Claessen BEPM; Chandrasekhar J; Vogel B; Kalkman DN; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail G; Ferrer-Grazia MC; Naber C; Kievit P; Baber U; Sharma S; Morice MC; Chieffo A; Mehran R;
    Catheter Cardiovasc Interv; 2019 May; 93(6):1124-1131. PubMed ID: 30511802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of extent of coronary artery disease and percutaneous revascularization assessed by the SYNTAX score on outcomes following transcatheter aortic valve replacement.
    Stephan T; Thoma E; Rattka M; Felbel D; Buckert D; Rottbauer W; Gonska B; Markovic S
    BMC Cardiovasc Disord; 2021 Nov; 21(1):568. PubMed ID: 34847875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary artery disease and reasonably incomplete coronary revascularization in high-risk patients undergoing transcatheter aortic valve implantation.
    Saia F; Palmerini T; Compagnone M; Battistini P; Moretti C; Taglieri N; Marcelli C; Bruno AG; Ghetti G; Corsini A; Bacchi Reggiani ML; Marrozzini C; Rapezzi C
    Catheter Cardiovasc Interv; 2020 Jan; 95(1):19-27. PubMed ID: 30916884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcatheter aortic valve replacement- management of patients with significant coronary artery disease undergoing aortic valve interventions: surgical compared to catheter-based approaches in hybrid procedures.
    Baumbach H; Schairer ER; Wachter K; Rustenbach C; Ahad S; Stan A; Hill S; Bramlage P; Franke UFW; Schäufele T
    BMC Cardiovasc Disord; 2019 May; 19(1):108. PubMed ID: 31088373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary artery disease, revascularization, and clinical outcomes in transcatheter aortic valve replacement: Real-world results from the East Denmark Heart Registry.
    Millan-Iturbe O; Sawaya FJ; Lønborg J; Chow DHF; Bieliauskas G; Engstrøm T; Søndergaard L; De Backer O
    Catheter Cardiovasc Interv; 2018 Oct; 92(4):818-826. PubMed ID: 29214718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Coronary Artery Revascularization Completeness on Outcomes of Patients With Coronary Artery Disease Undergoing Transcatheter Aortic Valve Replacement: A Meta-Analysis of Studies Using the Residual SYNTAX Score (Synergy Between PCI With Taxus and Cardiac Surgery).
    Witberg G; Zusman O; Codner P; Assali A; Kornowski R
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e006000. PubMed ID: 29870384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-Year Outcomes of Transfemoral Transcatheter Aortic Valve Replacement or Surgical Aortic Valve Replacement in a Real World Population.
    Barbanti M; Tamburino C; D'Errigo P; Biancari F; Ranucci M; Rosato S; Santoro G; Fusco D; Seccareccia F;
    Circ Cardiovasc Interv; 2019 Jul; 12(7):e007825. PubMed ID: 31284737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic Effects of Coronary Disease Severity and Completeness of Revascularization on Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Witberg G; Regev E; Chen S; Assali A; Barbash IM; Planer D; Vaknin-Assa H; Guetta V; Vukasinovic V; Orvin K; Danenberg HD; Segev A; Kornowski R
    JACC Cardiovasc Interv; 2017 Jul; 10(14):1428-1435. PubMed ID: 28728656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Complex Coronary Artery Disease.
    Alperi A; Mohammadi S; Campelo-Parada F; Munoz-Garcia E; Nombela-Franco L; Faroux L; Veiga G; Serra V; Fischer Q; Pascual I; Asmarats L; Gutiérrez E; Regueiro A; Vilalta V; Ribeiro HB; Matta A; Munoz-Garcia A; Armijo G; Metz D; De la Torre Hernandez JM; Rodenas-Alesina E; Urena M; Moris C; Arzamendi D; Perez-Fuentes P; Fernandez-Nofrerias E; Campanha-Borges DC; Mesnier J; Voisine P; Dumont E; Kalavrouziotis D; Rodés-Cabau J
    JACC Cardiovasc Interv; 2021 Nov; 14(22):2490-2499. PubMed ID: 34794656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR).
    Herold J; Herold-Vlanti V; Sherif M; Luani B; Breyer C; Bonaventura K; Braun-Dullaeus R
    BMC Cardiovasc Disord; 2017 Dec; 17(1):298. PubMed ID: 29262768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfemoral TAVR in Nonagenarians: From the CENTER Collaboration.
    Vlastra W; Chandrasekhar J; Vendrik J; Gutierrez-Ibanes E; Tchétché D; de Brito FS; Barbanti M; Kornowski R; Latib A; D'Onofrio A; Ribichini F; Baan J; Tijssen JGP; Pan M; Dumonteil N; Mangione JA; Sartori S; D'Errigo P; Tarantini G; Lunardi M; Orvin K; Pagnesi M; Sanchez Gila J; Modine T; Dangas G; Mehran R; Piek JJ; Delewi R
    JACC Cardiovasc Interv; 2019 May; 12(10):911-920. PubMed ID: 31122347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of coronary artery disease in patients undergoing transfemoral transcatheter aortic valve implantation.
    Shamekhi J; Stundl A; Weber M; Mellert F; Welz A; Grube E; Nickenig G; Werner N; Sinning JM
    Int J Cardiol; 2017 Oct; 245():215-221. PubMed ID: 28789844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter aortic valve replacement and percutaneous coronary intervention versus surgical aortic valve replacement and coronary artery bypass grafting in patients with severe aortic stenosis and concomitant coronary artery disease: A systematic review and meta-analysis.
    Kotronias RA; Bray JH; Scarsini R; Rajasundaram S; Terentes-Printzios D; De Maria GL; Kharbanda RK; Mamas MA; Bagur R; Banning AP
    Catheter Cardiovasc Interv; 2020 Nov; 96(5):1113-1125. PubMed ID: 32662594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes and revascularization strategies in patients with low-flow, low-gradient severe aortic valve stenosis according to the assigned treatment modality.
    O'Sullivan CJ; Englberger L; Hosek N; Heg D; Cao D; Stefanini GG; Stortecky S; Gloekler S; Spitzer E; Tüller D; Huber C; Pilgrim T; Praz F; Buellesfeld L; Khattab AA; Carrel T; Meier B; Windecker S; Wenaweser P
    JACC Cardiovasc Interv; 2015 Apr; 8(5):704-17. PubMed ID: 25946444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry.
    Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail G; Sharma S; Ferrer MC; Naber C; Kievit P; Baber U; Snyder C; Sharma M; Morice MC; Mehran R;
    JACC Cardiovasc Interv; 2018 Jan; 11(1):1-12. PubMed ID: 29301640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose approach matter? A meta-analysis of outcomes following transfemoral versus transapical transcatheter aortic valve replacement.
    Guo R; Xie M; Yim WY; Wu W; Jiang W; Wang Y; Hu X
    BMC Cardiovasc Disord; 2021 Jul; 21(1):358. PubMed ID: 34320946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation.
    Costa G; Pilgrim T; Amat Santos IJ; De Backer O; Kim WK; Barbosa Ribeiro H; Saia F; Bunc M; Tchetche D; Garot P; Ribichini FL; Mylotte D; Burzotta F; Watanabe Y; De Marco F; Tesorio T; Rheude T; Tocci M; Franzone A; Valvo R; Savontaus M; Wienemann H; Porto I; Gandolfo C; Iadanza A; Bortone AS; Mach M; Latib A; Biasco L; Taramasso M; Zimarino M; Tomii D; Nuyens P; Sondergaard L; Camara SF; Palmerini T; Orzalkiewicz M; Steblovnik K; Degrelle B; Gautier A; Del Sole PA; Mainardi A; Pighi M; Lunardi M; Kawashima H; Criscione E; Cesario V; Biancari F; Zanin F; Joner M; Esposito G; Adam M; Grube E; Baldus S; De Marzo V; Piredda E; Cannata S; Iacovelli F; Andreas M; Frittitta V; Dipietro E; Reddavid C; Strazzieri O; Motta S; Angellotti D; Sgroi C; Kargoli F; Tamburino C; Barbanti M;
    Circ Cardiovasc Interv; 2022 Dec; 15(12):e012417. PubMed ID: 36538579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous Coronary Intervention of Complex Calcific Coronary Lesions Utilizing Orbital Atherectomy Prior to Transcatheter Aortic Valve Replacement.
    Beohar N; Mohammed N; Kherada N; Igyarto Z; Martinsen BJ
    Cardiovasc Revasc Med; 2022 Apr; 37():82-85. PubMed ID: 34261617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant coronary artery disease and its management in patients referred to transcatheter aortic valve implantation: Insights from the POL-TAVI Registry.
    Huczek Z; Zbroński K; Grodecki K; Scisło P; Rymuza B; Kochman J; Dąbrowski M; Witkowski A; Wojakowski W; Parma R; Ochała A; Grygier M; Olasińska-Wiśniewska A; Araszkiewicz A; Jagielak D; Ciećwierz D; Puchta D; Paczwa K; Filipiak KJ; Wilimski R; Zembala M; Opolski G
    Catheter Cardiovasc Interv; 2018 Jan; 91(1):115-123. PubMed ID: 28843025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.